From August 1, 2026 to August 26, 2026, 42,200 shares of common stock were acquired through market purchases, totaling 25,686,800 yen. This transaction is part of the previously announced plan approved by the board on February 12, 2026 to acquire up to 250,000 shares (4.4%), with an acquisition period from February 13, 2026 to December 31, 2026; the company has announced that the acquisition has now ended.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"6090","jir_company_name":"Human Metabolome Technologies, Inc.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-08-27","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/08\/6090-20260827-01.pdf","jir_short_summary":"From August 1, 2026 to August 26, 2026, 42,200 shares of common stock were acquired through market purchases, totaling 25,686,800 yen. This transaction is part of the previously announced plan approved by the board on February 12, 2026 to acquire up to 250,000 shares (4.4%), with an acquisition period from February 13, 2026 to December 31, 2026; the company has announced that the acquisition has now ended.","jir_summary":"### Overview of treasury stock acquisitions\nThis notice reports the status and completion of treasury stock acquisitions pursuant to the provisions of Article 165, Paragraph 2 and Article 156 of the Companies Act. This time, 42,200 shares of common stock were acquired through market purchases, for a total amount of 25,686,800 yen. The acquisition period was set from August 1 to August 26 (on an execution basis), and the transactions were conducted as part of the purposes decided by the Board of Directors.\n\n### Background and outlook\nIn the February 12, 2026 board resolution, the total number of treasury stock to be acquired was capped at 250,000 shares (4.4% of issued shares, up to 200 million yen). The acquisition period was set from February 13, 2026 to December 31, 2026. This notice also announces that acquisitions under that resolution have ended. The impact on future capital policy and dilution control are not described in this\u516c\u544a.","jir_financial_highlights":"Total number of shares acquired: 42,200 shares (Unknown)\nTotal amount of shares acquired: 25,686,800 yen (Unknown)\nAcquisition period: August 1, 2026 to August 26, 2026 (Unknown)","jir_category":"","jir_hashtags":"#Human Metabolome Technologies, Inc. treasury stock acquisition","jir_key_figures":"Total number of shares acquired: 42,200 shares\nTotal amount of shares acquired: 25,686,800 yen\nCap on shares: 250,000 shares (4.4%)","jir_meta_title":"\u3010Human Metabolome Technologies\u3011 treasury stock acquisition status disclosed\uff5cAugust 2026","jir_meta_description":"Human Metabolome Technologies acquired 42,200 treasury shares via market purchases for a total of 25,686,800 yen, with an acquisition period from August 1 to 26. The cap is 250,000 shares (4.4%), and acquisitions have been disclosed as ended.","jir_og_title":"\u3010Human Metabolome Technologies\u3011 treasury stock acquisition status disclosed\uff5cAugust 2026","jir_og_description":"Disclosure of treasury stock acquisition status and completion. Shares acquired: 42,200; total amount: 25,686,800 yen. Cap: 250,000 shares. No details on future impact of capital policy in this notice.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":60381,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"share_buyback","footnotes":""},"sector":[],"importance":[],"class_list":["post-107652","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n